3.0.0 3175 2023-01-13T04:50:57Z 2023-01-13T04:50:57Z Senate S S 2006-05-25 109 ssju00 Judiciary Committee Senate Standing Referred to 2006-05-25T23:47:37Z 2006-05-25 ssju00 Judiciary Committee Senate Read twice and referred to the Committee on the Judiciary. (text of measure as introduced: CR S5247-5252) IntroReferral 2006-05-25 Sponsor introductory remarks on measure. (CR S5245-5247) IntroReferral B00100 9 Library of Congress 2006-05-25 Introduced in Senate IntroReferral 10000 9 Library of Congress L000174 Sen. Leahy, Patrick J. [D-VT] Patrick Leahy D VT N Commerce Administrative remedies Congress Congressional reporting requirements Department of Commerce Developing countries Drug industry Drugs Executive reorganization Exports Federal advisory bodies Foreign Trade and International Finance Free trade Generic drugs Government Operations and Politics Health Intellectual property International Affairs Labeling Law Licenses Nongovernmental organizations Patent infringement Patents Trade agreements World health Commerce 00 2006-05-25 Introduced in Senate 2006-07-25T19:58:43Z Life-Saving Medicines Export Act of 2006 - Allows the Director of the U.S. Patent and Trademark Office (USPTO) to issue a compulsory license to a generic manufacturer of a pharmaceutical product or a patented product needed to prevent or treat potentially life threatening public health problems for the purposes of manufacturing and exporting such pharmaceutical products to an eligible country. Allows exportation to a country that is a least developed country as designated by the United Nations (U.N.) or a country that lacks sufficient manufacturing capacities to produce the pharmaceutical product. Sets forth application requirements for compulsory licenses, including that the manufacturer sought a voluntary license from the patent holder.

Requires the Director to establish an office within USPTO to assist applicants and eligible counties, nongovernmental organizations, or nations likely to become eligible countries in identifying companies in the United States which could provide pharmaceutical products under this Act.

Sets forth formulas for calculating the royalty amount that the holder of a compulsory license must pay to the patent holder.

Allows the Director to grant a compulsory license to a generic manufacturer on an expedited basis for a limited period for a pharmaceutical product to address a national emergency or other circumstances of extreme urgency.

Declares that it is not patent infringement to manufacture and export a pharmaceutical product in accordance with this Act.

Requires the Director to establish the National Advisory Board on Implementation of the General Council Decision to provide advice and guidance regarding the implementation and administration of the compulsory licensing program established under this Act.

]]> Life-Saving Medicines Export Act of 2006 Display Title Life-Saving Medicines Export Act of 2006 Official Title as Introduced A bill to amend title 35, United States code, with respect to establishing procedures for granting authority to the Under Secretary for Commerce for Intellectual Property and Director of the Patent and Trademark Office to grant compulsory patent licenses for exporting patented pharmaceutical products to certain countries consistent with international commitments made by the United States, and for other purposes. Introduced in Senate IS Short Titles as Introduced Life-Saving Medicines Export Act of 2006 Introduced in Senate 2006-05-25T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-109s3175is/xml/BILLS-109s3175is.xml 2006-05-25 Read twice and referred to the Committee on the Judiciary. (text of measure as introduced: CR S5247-5252) text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.